These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Uncomplicated lower urinary tract infection in women: new therapeutics].
    Author: Brumpt I.
    Journal: Rev Prat; 1990 May 11; 40(14):1271-4. PubMed ID: 2359933.
    Abstract:
    Some twenty years ago, its was generally agreed that bacterial cystitis should be treated for 7 to 10 days, but since that time numerous clinical studies have suggested that shorter, single-dose or three-day treatments were possible. The single-dose chemotherapy of bacterial cystitis in women is a new and different approach with several prerequisites: strict clinical indication; use of a microbiologically and pharmacokinetically appropriate agent whose effectiveness has been demonstrated by clinical trials; close clinical and microbiological follow-up after treatment. Amoxicillin, aminoglycosides and above all drugs with prolonged urinary excretion, such as trimethoprim-sulfamethoxazole and notably fluoroquinolones (including pefloxacine), have proved to be effective as single-dose treatment of bacterial cystitis in women. In patients whose cystitis relapses at very short intervals, continuous or intermittent low-dose antibacterial prophylaxis may be contemplated, using trimethoprim-sulfamethoxazole, nitrofurantoin, trimethoprim alone or a quinolone. American authors have suggested, in some special cases, a patient-administered single-dose therapy at home as soon as the first signs of relapse appear.
    [Abstract] [Full Text] [Related] [New Search]